You are here

StemMed, Ltd.

Company Information
Address 7000 Fannin Street
Suite 1960M
Houston, TX, 77030

http://www.stemmedcancer.com

Information

DUNS: 832672166

# of Employees: 3


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Oral Small Molecule STAT Inhibitor to Treat Cachexia in Chronic Kidney Disease

    Amount: $1,499,268.00

    DESCRIPTION provided by applicant Chronic kidney disease CKD is a major public health problem in the US with an estimated prevalence of million patients enter hemodialysis or perito ...

    STTRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Oral Small Molecule STAT3 Inhibitor to Treat Cachexia in Chronic Kidney Disease

    Amount: $215,557.00

    DESCRIPTION provided by applicant Chronic kidney disease CKD is a major public health problem in the US with an estimated prevalence of million patients enter hemodialysis or perito ...

    STTRPhase I2016Department of Health and Human Services
  3. Chemical probes that target Stat3 to treat cancer

    Amount: $277,365.00

    DESCRIPTION (provided by applicant): We have shown for the first time in human breast cancer patients that residual tumors after standard chemotherapy are enriched for a CD44+/CD24-/low population of ...

    STTRPhase I2012Department of Health and Human Services
US Flag An Official Website of the United States Government